These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 11342695)

  • 1. Guillain-Barré syndrome associated with IgG monospecific to ganglioside GD1b.
    Miyazaki T; Kusunoki S; Kaida K; Shiina M; Kanazawa I
    Neurology; 2001 May; 56(9):1227-9. PubMed ID: 11342695
    [TBL] [Abstract][Full Text] [Related]  

  • 2. GD1b-specific antibody induces ataxia in Guillain-Barre syndrome.
    Kaida K; Kamakura K; Ogawa G; Ueda M; Motoyoshi K; Arita M; Kusunoki S
    Neurology; 2008 Jul; 71(3):196-201. PubMed ID: 18625966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antiganglioside autoantibody profiles in Guillain-Barré syndrome].
    Caudie C; Vial C; Bancel J; Petiot P; Antoine JC; Gonnaud PM
    Ann Biol Clin (Paris); 2002; 60(5):589-97. PubMed ID: 12368145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical relevance of serum antibodies to GD1b in immune-mediated neuropathies.
    Taams NE; Notermans NC; Fokkink WR; Tio-Gillen AP; Huizinga R; Schreurs MWJ; Jacobs BC
    J Peripher Nerv Syst; 2018 Dec; 23(4):227-234. PubMed ID: 30101437
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Anti-GD1b IgG positive case of overlapping Ficher's and Guillain-Barré syndromes].
    Caudie C; Schandelong A; Rapoport F; Vial C
    Ann Biol Clin (Paris); 2004; 62(5):591-4. PubMed ID: 15355812
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Temporal profile of anti-ganglioside antibodies and their relation to clinical parameters and treatment in Guillain-Barré syndrome.
    Press R; Matá S; Lolli F; Zhu J; Andersson T; Link H
    J Neurol Sci; 2001 Sep; 190(1-2):41-7. PubMed ID: 11574105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fine specificities of anti-LM1 IgG antibodies in Guillain-Barré syndrome.
    Susuki K; Yuki N; Hirata K; Kuwabara S
    J Neurol Sci; 2002 Mar; 195(2):145-8. PubMed ID: 11897245
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of antibodies to ganglioside complexes and conduction blocks in axonal Guillain-Barré syndrome presenting as acute motor conduction block neuropathy.
    Créange A; Shahrizaila N; Salhi H; Lefaucheur JP; Yuki N
    J Peripher Nerv Syst; 2014 Jun; 19(2):115-20. PubMed ID: 24750296
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of serum antibody to GD1b ganglioside in patients with Guillain-Barré syndrome.
    Reuben S; Mathai A; Sumi MG; Nair MD; Radhakrishnan VV
    Indian J Med Res; 2001 Jun; 113():234-8. PubMed ID: 11816958
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of anti-ganglioside antibodies in Guillain-Barré syndrome and its variants by the agglutination assay.
    Alaedini A; Briani C; Wirguin I; Siciliano G; D'Avino C; Latov N
    J Neurol Sci; 2002 Apr; 196(1-2):41-4. PubMed ID: 11959155
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathogenetic mechanisms of autoimmune neuropathies caused by antiglycolipid antibodies].
    Kusunoki S
    Rinsho Shinkeigaku; 2001 Dec; 41(12):1141-3. PubMed ID: 12235820
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies to LM1 and LM1-containing ganglioside complexes in Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy.
    Kuwahara M; Suzuki S; Takada K; Kusunoki S
    J Neuroimmunol; 2011 Oct; 239(1-2):87-90. PubMed ID: 21914557
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Axonal Guillain-Barré syndrome: relation to anti-ganglioside antibodies and Campylobacter jejuni infection in Japan.
    Ogawara K; Kuwabara S; Mori M; Hattori T; Koga M; Yuki N
    Ann Neurol; 2000 Oct; 48(4):624-31. PubMed ID: 11026446
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anti-ganglioside complex antibodies associated with severe disability in GBS.
    Kaida K; Morita D; Kanzaki M; Kamakura K; Motoyoshi K; Hirakawa M; Kusunoki S
    J Neuroimmunol; 2007 Jan; 182(1-2):212-8. PubMed ID: 17113161
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ganglioside complexes as new target antigens in Guillain-Barré syndrome.
    Kaida K; Morita D; Kanzaki M; Kamakura K; Motoyoshi K; Hirakawa M; Kusunoki S
    Ann Neurol; 2004 Oct; 56(4):567-71. PubMed ID: 15389898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ataxic Guillain-Barré syndrome associated with anti-GM1b and anti-GalNAc-GD1a antibodies.
    Odaka M; Yuki N; Tatsumoto M; Tateno M; Hirata K
    J Neurol; 2004 Jan; 251(1):24-9. PubMed ID: 14999485
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ganglioside-specific IgG and IgA recruit leukocyte effector functions in Guillain-Barré syndrome.
    van Sorge NM; Yuki N; Koga M; Susuki K; Jansen MD; van Kooten C; Wokke JH; van de Winkel JG; van der Pol WL; van den Berg LH
    J Neuroimmunol; 2007 Jan; 182(1-2):177-84. PubMed ID: 17156858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibodies to GM1(NeuGc) in Guillain-Barré syndrome after ganglioside therapy.
    Odaka M; Yuki N; Nobile-Orazio E; Carpo M; Hirata K
    J Neurol Sci; 2000 Apr; 175(2):96-106. PubMed ID: 10831769
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes of Serum IgG Dimer Levels after Treatment with IVIg in Guillain-Barré Syndrome.
    Svačina MKR; Röth P; Bobylev I; Sprenger A; Zhang G; Sheikh KA; Lehmann HC
    J Neuroimmune Pharmacol; 2019 Dec; 14(4):642-648. PubMed ID: 31515689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunoglobulin G subclass distribution of autoantibodies to gangliosides in patients with Guillain-Barre syndrome.
    Ilyas AA; Chen ZW; Cook SD; Mithen FA; Singhal BS
    Res Commun Mol Pathol Pharmacol; 2001 Jul; 109(1-2):115-23. PubMed ID: 11458979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.